Concepedia

Author

Kazuki Maesaka

The University of Osaka

Also Known As

K MAESAKA, K Maesaka, KAZUKI MAESAKA, Kazuki Maesaka

38

Publications

576

Citations

10

H-Index

11

Concepts

All Affiliations

The University of OsakaOsaka Police HospitalOsaka National HospitalKansai Rosai HospitalOsaka City General Hospital
KM

About

Kazuki Maesaka is an author at The University of Osaka specializing in hepatology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

62

2

Hepatology

1

1

62

3

Immunology

1

1

62

4

Pathology

1

1

62

5

Cancer Therapeutics

1

1

62

Kazuki Maesaka

×

11

Publications

541

Citations

10

H-Index

YearCitations

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

Hiroki Murai, Takahiro Kodama, Kazuki Maesaka,

Hepatology

2022

163

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori,

Cancers

2022

80

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

Yuta Myojin, Takahiro Kodama, Kazuki Maesaka,

Clinical Cancer Research

2020

73

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy

Takayuki Matsumae, Takahiro Kodama, Yuta Myojin,

Cancers

2022

62

Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada,

Hepatology Research

2022

55

Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada,

Hepatology Research

2021

44

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada,

PLoS ONE

2023

17

Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada,

Hepatology Research

2019

13

Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment

Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada,

Hepatology Research

2021

12

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

Yuki Tahata, Ryotaro Sakamori, Kazuki Maesaka,

Hepatology Research

2022

12

Page 1